MENU
CVKD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cadrenal Therapeutics (CVKD) Earnings Date & Reports
Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions... Show more
A.I. Advisor
published Earnings
CVKD is expected to report earnings to rise 34.21% to -152 cents per share on November 05
Q3'26
Est.
$-1.53
Q2'26
Beat
by $0.27
Q1'26
Beat
by $0.31
Q4'25
Beat
by $0.05
Q3'25
Beat
by $0.08
The last earnings report on August 13 showed earnings per share of -113 cents, beating the estimate of -140 cents. With 78.45K shares outstanding, the current market capitalization sits at 4.00M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
5
Web
https://www.cadrenal.com